Updated COVID vaccine 71% effective against hospitalization for older adults --Dutch study
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Nearly 17,000 people may have died after taking hydroxycholoroquine during the first wave of Covid-19, according to a study by French researchers.
Submitted by mike kraft on
A study involving hospitalized adults today in JAMA Network Open finds that severe COVID-19 negatively affects brain health, but no more so than pneumonia, heart attack, or other critical illnesses.
...
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on
Due to its rapid growth and potential to add to the respiratory virus burden in Northern Hemisphere countries, the World Health Organization (WHO) today designated JN.1, part of the BA.2.86 SARS-CoV-2 lineage, as its own variant of interest.
Over the past month, the proportion of JN.1 viruses has rapidly increased, rising from 3.3% in early November to 27.1% by early December. Countries reporting the highest proportions include France, the United States, Singapore, Canada, and the United Kingdom.
Submitted by mike kraft on
Submitted by mike kraft on
Submitted by mike kraft on